| Name | Plaza Drug Of London |
|---|---|
| Organization Name | Plaza Drug Of London Llc |
| Location | 731 N Laurel Rd, London, Kentucky 40741 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (606) 657-5245 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
"A mentally ill man who bathed in and drank from a contaminated river most likely was the first person to be infected" with cholera in the outbreak that began in Haiti in October 2010, researchers from Partners in Health said in a study published Monday in the American Journal of Tropical Medicine and Hygiene, the Associated Press/Washington Post reports (1/9).
Alexza Pharmaceuticals, Inc. announced today that it has executed a $15 million working capital loan agreement with Hercules Technology Growth Capital. The funds available under the loan will be used for capital equipment and working capital purposes. In connection with the loan, Alexza issued Hercules warrants to purchase 376,394 shares of common stock at an exercise price of $2.69 per share, which was the 50-day average daily weighted average trading price at the time the term sheet for the loan was issued by Hercules.
Children are more vulnerable than adults to the adverse effects of air pollution for several reasons. First, children have increased exposure to many air pollutants because they spend more time outside, have higher breathing rates and higher levels of physical activity compared with adults.
While blood and marrow transplants can save the life of a pediatric cancer patient, research out of the University of Alabama at Birmingham found that those patients may be at an increased risk of premature death even years or decades after the procedure as compared with the general population.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells, or tumor-initiating cells, today announced that patient dosing has begun in a Phase I clinical trial of OMP-54F28 in patients with advanced solid tumor cancers.
› Verified 4 days ago
| NPI Number | 1720537251 |
| Organization Name | PLAZA DRUG OF LONDON LLC |
| Doing Business As | PLAZA DRUG OF LONDON |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 731 N Laurel Rd, London, KY 40741 |
| Phone Number | 606-657-5245 |
News Archive
"A mentally ill man who bathed in and drank from a contaminated river most likely was the first person to be infected" with cholera in the outbreak that began in Haiti in October 2010, researchers from Partners in Health said in a study published Monday in the American Journal of Tropical Medicine and Hygiene, the Associated Press/Washington Post reports (1/9).
Alexza Pharmaceuticals, Inc. announced today that it has executed a $15 million working capital loan agreement with Hercules Technology Growth Capital. The funds available under the loan will be used for capital equipment and working capital purposes. In connection with the loan, Alexza issued Hercules warrants to purchase 376,394 shares of common stock at an exercise price of $2.69 per share, which was the 50-day average daily weighted average trading price at the time the term sheet for the loan was issued by Hercules.
Children are more vulnerable than adults to the adverse effects of air pollution for several reasons. First, children have increased exposure to many air pollutants because they spend more time outside, have higher breathing rates and higher levels of physical activity compared with adults.
While blood and marrow transplants can save the life of a pediatric cancer patient, research out of the University of Alabama at Birmingham found that those patients may be at an increased risk of premature death even years or decades after the procedure as compared with the general population.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells, or tumor-initiating cells, today announced that patient dosing has begun in a Phase I clinical trial of OMP-54F28 in patients with advanced solid tumor cancers.
› Verified 4 days ago
| NPI Number | 1770904989 |
| Organization Name | PLAZA DRUG OF LONDON LLC |
| Doing Business As | PLAZA DRUG OF LONDON |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 731 N Laurel Rd, London, KY 40741 |
| Phone Number | 606-657-5245 |
News Archive
"A mentally ill man who bathed in and drank from a contaminated river most likely was the first person to be infected" with cholera in the outbreak that began in Haiti in October 2010, researchers from Partners in Health said in a study published Monday in the American Journal of Tropical Medicine and Hygiene, the Associated Press/Washington Post reports (1/9).
Alexza Pharmaceuticals, Inc. announced today that it has executed a $15 million working capital loan agreement with Hercules Technology Growth Capital. The funds available under the loan will be used for capital equipment and working capital purposes. In connection with the loan, Alexza issued Hercules warrants to purchase 376,394 shares of common stock at an exercise price of $2.69 per share, which was the 50-day average daily weighted average trading price at the time the term sheet for the loan was issued by Hercules.
Children are more vulnerable than adults to the adverse effects of air pollution for several reasons. First, children have increased exposure to many air pollutants because they spend more time outside, have higher breathing rates and higher levels of physical activity compared with adults.
While blood and marrow transplants can save the life of a pediatric cancer patient, research out of the University of Alabama at Birmingham found that those patients may be at an increased risk of premature death even years or decades after the procedure as compared with the general population.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells, or tumor-initiating cells, today announced that patient dosing has begun in a Phase I clinical trial of OMP-54F28 in patients with advanced solid tumor cancers.
› Verified 4 days ago
News Archive
"A mentally ill man who bathed in and drank from a contaminated river most likely was the first person to be infected" with cholera in the outbreak that began in Haiti in October 2010, researchers from Partners in Health said in a study published Monday in the American Journal of Tropical Medicine and Hygiene, the Associated Press/Washington Post reports (1/9).
Alexza Pharmaceuticals, Inc. announced today that it has executed a $15 million working capital loan agreement with Hercules Technology Growth Capital. The funds available under the loan will be used for capital equipment and working capital purposes. In connection with the loan, Alexza issued Hercules warrants to purchase 376,394 shares of common stock at an exercise price of $2.69 per share, which was the 50-day average daily weighted average trading price at the time the term sheet for the loan was issued by Hercules.
Children are more vulnerable than adults to the adverse effects of air pollution for several reasons. First, children have increased exposure to many air pollutants because they spend more time outside, have higher breathing rates and higher levels of physical activity compared with adults.
While blood and marrow transplants can save the life of a pediatric cancer patient, research out of the University of Alabama at Birmingham found that those patients may be at an increased risk of premature death even years or decades after the procedure as compared with the general population.
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells, or tumor-initiating cells, today announced that patient dosing has begun in a Phase I clinical trial of OMP-54F28 in patients with advanced solid tumor cancers.
› Verified 4 days ago
20/20 Eyecare Of London, Pllc Type: Medicare Supplier Location: 103 Chera Lynn St, London, Kentucky 40741 Phone: (606) 878-7500 | |
Elite Medical Supply Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1501 S Main St, London, Kentucky 40741 Phone: (606) 330-0570 | |
Huffman And Huffman Psc Type: Medicare Supplier Location: 503 N Main St, London, Kentucky 40741 Phone: (606) 877-1877 | |
Kenney Orthopedics Of London Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 100 London Mountain View Dr, London, Kentucky 40741 Phone: (606) 862-9000 | |
Cvs Pharmacy #06342 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2104 North Main St, London, Kentucky 40741 Phone: (606) 878-7344 |